Australia markets close in 2 hours 28 minutes

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.1000+0.0600 (+1.97%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.0400
Bid1.2800 x 2900
Ask3.1800 x 1200
Day's range3.0400 - 3.2000
52-week range3.0100 - 11.9500
Avg. volume10,953
Market cap83.921M
Beta (5Y monthly)-1.21
PE ratio (TTM)N/A
EPS (TTM)-2.2020
Earnings date14 June 2022 - 20 June 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est10.03
  • GlobeNewswire

    CENTOGENE to Present at the H.C. Wainwright Global Investment Conference

    CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022, and invites investors to participate via virtual one-on-one meetings. Please see additional details below: H.C. Wainwright Global I

  • Simply Wall St.

    Centogene (NASDAQ:CNTG) investors are sitting on a loss of 66% if they invested a year ago

    Even the best stock pickers will make plenty of bad investments. Unfortunately, shareholders of Centogene N.V...

  • GlobeNewswire

    CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

    Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing access to genetic testing for patients with rare metabolic and rare neurodegenerative diseasesThe global market access and expansion partnership initially established in 2015 aims to provide an efficient and timely diagnosis to patientsDiagnosis remains crucial for patients, leading them towards suitable readily available t